Equity Overview
Price & Market Data
Price: $4.17
Daily Change: -$1.30 / 31.18%
Range: $4.02 - $4.70
Market Cap: $984,410,304
Volume: 20,521,704
Performance Metrics
1 Week: -21.48%
1 Month: -15.37%
3 Months: -22.95%
6 Months: -31.28%
1 Year: -35.47%
YTD: -18.54%
Company Details
Employees: 395
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.